ADIPOQ and metastatic neoplasm: Interestingly, the analysis of the metabolic and clinical phenotypes—including modulation of adipokines (i.e., adiponectin) and miRNAs regulating metabolism—underlying the development of metastatic disease, which remains the principal cause of breast cancer-related deaths, may lead to the identification of more effective targeted approaches to prevent and treat metastases.